Press "Enter" to skip to content

Inovio First To Advance Lassa Fever Candidate Vaccine Into A Clinical Trial – Clinical Leader

admin 0

Inovio First To Advance Lassa Fever Candidate Vaccine Into A Clinical Trial  Clinical Leader

Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, today announced it has dosed subjects in a Phase 1, first-in-human clinical trial to…

“nigeria cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your e-mail address will not be published. Required fields are marked *